NEW ATAI-Logo_Primary.png
atai Life Sciences Announces Pricing of Upsized Initial Public Offering
June 17, 2021 23:21 ET | atai Life Sciences
BERLIN, June 17, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences B.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Tryp Therapeutics Inc. Chairman and CEO Greg McKee
June 17, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Brain Scientific Enters into Merger Agreement with Piezo Motion
June 16, 2021 08:30 ET | Brain Scientific Inc.
NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announces today that it has entered into...
Generic Oncology Drugs Market Growth Sturdy at 6.3% CAGR to Outstrip $36,029.60 Million by 2027 - COVID-19 Impact and Global Analysis by
June 16, 2021 08:10 ET | The Insight Partners
Pune, India., June 16, 2021 (GLOBE NEWSWIRE) -- Generic Oncology Drugs Market: Key InsightsAccording to our new research study on “Generic Oncology Drugs Market to 2027 – Global Analysis and...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Appoints Laura L. Parks, Ph.D. to Board of Directors
June 16, 2021 07:00 ET | Recro Pharma, Inc.
EXTON, Pa., June 16, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Xphyto logo.jpg
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies
June 15, 2021 11:10 ET | XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...
visiongain Logo.png
North American Molecular Diagnostics Market worth US$12,058.3 Million by 2031: Visiongain Research Inc.
June 15, 2021 09:00 ET | Visiongain Ltd
Visiongain has published a new report on “North America Molecular Diagnostics Market, 2021-2031”. Forecasts By Technology {Polymerase Chain Reaction (Multiplex PCR, Other PCR), Isothermal Nucleic Acid...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues First Quarter Financial Results
June 15, 2021 08:45 ET | Polydex Pharmaceuticals Limited
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2022, the period ended April...
Global Biologics Safety Testing Market Size to Grow at a CAGR of 12.3% from 2021 to 2030
June 15, 2021 06:30 ET | Quince Market Insights
Pune, India, June 15, 2021 (GLOBE NEWSWIRE) -- The global biologics safety testing market has been estimated to reach USD 3.0 billion in 2021 and is projected to grow at a CAGR of 12.3% during the...
visiongain Logo.png
Clinical Laboratory Tests Market Worth US$421.06 billion by 2031: Visiongain Research Inc.
June 14, 2021 09:00 ET | Visiongain Ltd
Visiongain has published a new report on “Clinical Laboratory Tests Market Report Forecast 2021-2031”. Forecasts by Type (Basic Metabolic Panel Tests, Complete Blood Count, HGB/HCT Tests, Electrolytes...